GMED250117C70000
- 12.70
- 0.000.00%
Globus Medical Newsroom
Reasons to Add GMED Stock to Your Portfolio Right Now
Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?
Investors in Globus Medical (NYSE:GMED) Have Seen Notable Returns of 58% Over the Past Year
RBC Capital Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $101
Piper Sandler Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $100
Piper Sandler Reaffirms Their Buy Rating on Globus Medical (GMED)
16 Analysts Have This To Say About Globus Medical
Truist Financial Maintains Globus Medical(GMED.US) With Hold Rating, Raises Target Price to $90
RBC Raises Price Target on Globus Medical to $101 From $92, Keeps Outperform Rating
Top Picks for 2025 in Healthcare, Consumer, Tech, Industrials, Energy and More
Roth MKM Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $115
BTIG Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $91
Jefferies Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $100
Globus Medical (GMED) Gets a Buy From Jefferies
CCORF Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $92
BTIG Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $91
Bone Marrow Aspirate Concentrates Industry Report, Featuring Profiles of 45+ Key Players Including Arthrex, Cesca Therapeutics, Globus Medical, Ranfac, Terumo and Zimmer Biomet Holdings
Globus Medical Is Maintained at Overweight by Wells Fargo
Wells Fargo Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $95
Wells Fargo Reaffirms Their Buy Rating on Globus Medical (GMED)